The Evolving Role of PARP Inhibition in the Management of
Ovarian Cancer — Faculty Presentation 1: Integration of
PARP-Inhibitor Maintenance Therapy into the Management of Newly
Diagnosed Ovarian Cancer — Dr Westin.
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.